Eutamene, Beaufrand Harkat C, Theodorou V. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2018 ABSTRACT Introduction: The intestinal barrier controls the absorption of nutrients and water whilst helping to prevent the entry of toxins and pathogenic micro-organisms from the lumen into the tissues. Deficiencies in the barrier are associated with various [...]
Servi B, Ranzini F. Protective efficacy of antidiarrheal agents in a permeability model of Escherichia coli-infected CacoGoblet® cells. Future Microbiol. 2017 Oct 25. Future Microbiol. 2017 Oct 25. Abstract: Aim: To compare the protective efficacy of gelatine tannate/probiotic with other antidiarrheal agents in Escherichia coli-inoculated CacoGoblet® cells. Methods: Four test compounds [...]
New partnership: Xilaplus® AF in Turkey Noventure is delighted to announce its new partnership with Generica İlaç to market Noventure’s Xilaplus® AF in Turkey. Xilaplus® AF is a Class IIa CE marked medical device specifically formulated for the control and reduction of diarrheal events of various etiologies. Xilaplus® AF acts [...]
Annamaria Staiano Italian Journal of Pediatrics 2017, 43(Suppl 1): A2 Diarrhoea in children still has a major impact on health-related social costs, affecting approximately 2 billion children younger than 5 years every year, and determining 2 million deaths, mostly in Africa and Asia. [1] According to WHO diarrhea consists in [...]
Ford et al. N Engl J Med 2017; 376:2566-78 New article in NEJM supports the role of increased intestinal permeability in the pathophysiology of IBS. Increased intestinal permeability and tight junctions alterations trigger an inflammatory reaction which alters visceral neuromuscular function, leading to IBS symptoms like abdominal pain and diarrhea [...]
L. Bueno et al. UEG Journal – United European Gastroenterology Journal, Oct.2013: Vol. 1, Supl. 1; ISSN 2050-6406 (print) ISSN 2050-6414 (online) – Pags A75-A76 Introduction: Gelatine (GEL) stabilised by cross-linking with tannic acid (TA) forms gelatine tannate (GT). GT is approved as medical device for the oral treatment of diarrhoea [...]
Freli V. et al. Presented at GFHGHP 2012. Presented as oral communication at the 33rd edition of the Congress from the Groupe Francophone d’Hépato-Gastroentérologie et Nutrition Pédiatriques in Nantes, France, March 2012. Abstract: New insights into the mechanism of action of gelatine tannate for acute diarrhoea. Part 1: filmforming effect. [...]
In order to further disseminate its proprietary barrier technology, on which the new concept “mucoprotection” is based, and as part of its continuous investment in its products´ reputation, Noventure has just participated in this year´s ESPGHAN Congress, held in Prague. Pediatric gastroenterologists are a key target group for the recommendation [...]
L. Lopetuso, C. Graziani, A. Guarino, A. Lamborghini, S. Masi, V. Stanghellini Eur Rev Med Pharmacol Sci . 2017; 21 (4): 873-883 Researchers from the A. Gemelli Foundation, School of Medicine, Rome, Italy have published an extensive review on the role of Gelatin tannate and tyndallized probiotics (Tasectan Duo) in [...]
Jess Torres-Herrera, and Gabriel Torres-Ruiz. Current Drug Therapy, 2017, 12, 1-6 Background: Gelatin tannate is bowel selective, safe and effective, and acts locally to form a biofilm. As an adjuvant to oral rehydration solution (ORS), gelatin tannate acts as a mucoprotectant in the management of acute diarrhea in children. Objective: [...]